News Daily News TCT 2018 High Mortality but Durable Results With Valve-in-Valve TAVR Michael O'Riordan September 23, 2018
News Conference News TCT 2018 CTO PCI Patients With CKD Have More Acute Kidney Injury but Not Dialysis or TLF Over 2 Years Yael L. Maxwell September 23, 2018
News Conference News TCT 2018 Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study Michael O'Riordan September 22, 2018
News Conference News TCT 2018 IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease Todd Neale September 22, 2018
News Conference News TCT 2018 TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers Todd Neale September 22, 2018
News Conference News TCT 2018 CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro Michael O'Riordan September 22, 2018
News Conference News TCT 2018 ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year Yael L. Maxwell September 22, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents Shelley Wood September 22, 2018
News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
News Conference News TCT 2018 Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO Todd Neale September 21, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Conference News TCT 2017 CrossBoss First Shows Promise for Antegrade CTO PCI TCT Daily Staff November 07, 2017
News Conference News TCT 2017 FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost L.A. McKeown November 02, 2017
Presentation TCT 2017 TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu October 31, 2017
News Conference News TCT 2017 Long-term Absorb BVS Data Continue to Disappoint Michael O'Riordan October 31, 2017
News Conference News TCT 2017 Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year Yael L. Maxwell October 30, 2017